中国卒中杂志 ›› 2023, Vol. 18 ›› Issue (02): 145-162.DOI: 10.3969/j.issn.1673-5765.2023.02.003
王昱懿, 赵威, 段婉莹, 杨中华, 刘丽萍
收稿日期:
2023-02-03
出版日期:
2023-02-20
发布日期:
2023-02-20
通讯作者:
刘丽萍 lipingsister@gmail.com
Received:
2023-02-03
Online:
2023-02-20
Published:
2023-02-20
王昱懿, 赵威, 段婉莹, 杨中华, 刘丽萍. 神经重症:回眸2022[J]. 中国卒中杂志, 2023, 18(02): 145-162.
WANG Yuyi, ZHAO Wei, DUAN Wanying, YANG Zhonghua, LIU Liping.
[1] LIU X F,DAI Q L,YE R D,et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion(BEST):an open-label,randomised controlled trial[J]. Lancet Neurol,2020,19(2):115-122. [2] LANGEZAAL LCM,VAN DER HOEVEN EJRJ,MONT’ALVERNE FJA,et al. Endovascular therapy for stroke due to basilar-artery occlusion[J]. N Engl J Med,2021,384(20):1910-1920. [3] JOVIN T G,LI C H,WU L F,et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion[J]. N Engl J Med,2022,387(15):1373-1384. [4] TAO C R,NOGUEIRA R G,ZHU Y Y,et al. Trial of endovascular treatment of acute basilar-artery occlusion[J]. N Engl J Med,2022,387(15):1361-1372. [5] SARRAJ A,GROTTA J C,PUJARA D K,et al. Triage imaging and outcome measures for large core stroke thrombectomy - a systematic review and meta-analysis[J]. J Neurointerv Surg,2020,12(12):1172-1179. [6] YOSHIMURA S,SAKAI N,YAMAGAMI H,et al. Endovascular therapy for acute stroke with a large ischemic region[J]. N Engl J Med,2022,386(14):1303-1313. [7] NIE X M,LENG X Y,MIAO Z R,et al. Clinically ineffective reperfusion after endovascular therapy in acute ischemic stroke[J]. Stroke,2023,54(3):873-881. [8] XIE Y,OPPENHEIM C,GUILLEMIN F,et al. Pretreatment lesional volume impacts clinical outcome and thrombectomy efficacy[J]. Ann Neurol,2018,83(1):178-185. [9] OSPEL J M,HILL M D,DEMCHUK A,et al. Clinical impact of EVT with failed reperfusion in patients with acute ischemic stroke:results from the ESCAPE and ESCAPE-NA1 trials[J]. Neuroradiology,2021,63(11):1883-1889. [10] POWERS W J,RABINSTEIN A A,ACKERSON T,et al. Guidelines for the early management of patients with acute ischemic stroke:2019 update to the 2018 guidelines for the early management of acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2019,50(12):e344-e418[2023-02-02]. https://doi.org/10.1161/STR.0000000000000211. [11] GUO Y J,LIN Y P,TANG Y F,et al. Safety and efficacy of early antiplatelet therapy in acute ischemic stroke patients receiving endovascular treatment:a systematic review and meta-analysis[J/OL]. J Clin Neurosci,2019,66:45-50[2023-02-02]. https://doi.org/10.1016/j.jocn.2019.05.028. [12] YANG M,HUO X C,GAO F,et al. Safety and efficacy of heparinization during mechanical thrombectomy in acute ischemic stroke[J/OL]. Front Neurol,2019,10:299[2023-02-02]. https://doi.org/10.3389/fneur.2019.00299. [13] BERGE E,WHITELEY W,AUDEBERT H,et al. European Stroke Organisation(ESO)guidelines on intravenous thrombolysis for acute ischaemic stroke[J]. Eur Stroke J,2021,6(1):1-62. [14] VAN DER STEEN W,VAN DE GRAAF R A,CHALOS V,et al. Safety and efficacy of aspirin,unfractionated heparin,both,or neither during endovascular stroke treatment(MR CLEAN-MED):an open-label,multicentre,randomised controlled trial[J]. Lancet,2022,399(10329):1059-1069. [15] ALMEKHLAFI M A,COUTTS S B. Anti-thrombotics cause harm in the setting of stroke thrombectomy[J]. Lancet,2022,399(10329):1025-1026. [16] CANNON C P,WEINTRAUB W S,DEMOPOULOS L A,et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Ⅱb/Ⅲa inhibitor tirofiban[J]. N Engl J Med,2001,344(25):1879-1887. [17] VAN'T HOF A W,TEN BERG J,HEESTERMANS T,et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty(On-TIME 2):a multicentre,double-blind,randomised controlled trial[J]. Lancet,2008,372(9638):537-546. [18] CURA F A,BHATT D L,LINCOFF A M,et al. Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein Ⅱb/Ⅲa inhibition in complex atherosclerotic lesions[J]. Circulation,2000,102(1):28-34. [19] QIU Z M,LI F L,SANG H F,et al. Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke:the RESCUE BT randomized clinical trial[J]. JAMA,2022,328(6):543-553. [20] MULDER M J H L,ERGEZEN S,LINGSMA H F,et al. Baseline blood pressure effect on the benefit and safety of intra-arterial treatment in MR CLEAN(Multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in the Netherlands)[J]. Stroke,2017,48(7):1869-1876. [21] YANG P F,SONG L L,ZHANG Y W,et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke(ENCHANTED2/MT):a multicentre,open-label,blinded-endpoint,randomised controlled trial[J]. Lancet,2022,400(10363):1585-1596. [22] CZOSNYKA M,SMIELEWSKI P,KIRKPATRICK P,et al. Continuous assessment of the cerebral vasomotor reactivity in head injury[J]. Neurosurgery,1997,41(1):11-19. [23] CARNEY N,TOTTEN A M,O'REILLY C,et al. Guidelines for the management of severe traumatic brain injury,fourth edition[J]. Neurosurgery,2017,80(1):6-15. [24] TAS J,BEQIRI E,VAN KAAM R C,et al. Targeting autoregulation-guided cerebral perfusion pressure after traumatic brain injury(COGiTATE):a feasibility randomized controlled clinical trial[J]. J Neurotrauma,2021,38(20):2790-2800. [25] SANDRONI C,CRONBERG T,SEKHON M. Brain injury after cardiac arrest:pathophysiology,treatment,and prognosis[J]. Intensive Care Med,2021,47(12):1393-1414. [26] RUIJTER B J,KEIJZER H M,TJEPKEMA-CLOOSTERMANS M C,et al. Treating rhythmic and periodic EEG patterns in comatose survivors of cardiac arrest[J]. N Engl J Med,2022,386(8):724-734. [27] KJAERGAARD J,SCHMIDT H,MØLLER J E,et al. The "blood pressure and oxygenation targets in post resuscitation care,a randomized clinical trial":design and statistical analysis plan[J]. Trials,2022,23(1):177. [28] KJAERGAARD J,MØLLER J E,SCHMIDT H,et al. Blood-pressure targets in comatose survivors of cardiac arrest[J]. N Engl J Med,2022,387(16):1456-1466. [29] SCHMIDT H,KJAERGAARD J,HASSAGER C,et al. Oxygen targets in comatose survivors of cardiac arrest[J]. N Engl J Med,2022,387(16):1467-1476. [30] ZHAO J J,YUAN F,SONG C G,et al.Safety and efficacy of three enteral feeding strategies in patients with severe stroke in China(OPENS):a multicentre,prospective,randomised,open-label,blinded-endpoint trial[J]. Lancet Neurol,2022,21(4):319-328. [31] BÖSEL J,SCHILLER P,HOOK Y,et al. Stroke-related early tracheostomy versus prolonged orotracheal intubation in neurocritical care trial(SETPOINT):a randomized pilot trial[J]. Stroke,2013,44(1):21-28. [32] BÖSEL J,NIESEN W D,SALIH F,et al.Effect of early vs standard approach to tracheostomy on functional outcome at 6 months among patients with severe stroke receiving mechanical ventilation:the SETPOINT2 randomized clinical trial[J]. JAMA,2022,327(19):1899-1909. [33] HORN C M,SUN C H,NOGUEIRA R G,et al. Endovascular reperfusion and cooling in cerebral acute ischemia(ReCCLAIM I)[J]. J Neurointerv Surg,2014,6(2):91-95. [34] LYDEN P,HEMMEN T,GROTTA J,et al. Results of the ICTuS 2 trial(intravascular cooling in the treatment of stroke 2)[J]. Stroke,2016,47(12):2888-2895. [35] LEVY B,GIRERD N,AMOUR J,et al. Effect of moderate hypothermia vs normothermia on 30-day mortality in patients with cardiogenic shock receiving venoarterial extracorporeal membrane oxygenation:a randomized clinical trial[J]. JAMA,2022,327(5):442-453. |
[1] | 曹黎明, 任力杰. 急性缺血性卒中诊疗技术的进展与展望[J]. 中国卒中杂志, 2024, 19(9): 983-989. |
[2] | 符鹏程, 曹黎明, 朱佳倩, 赵桂玉, 徐格林. 大动脉粥样硬化性缺血性卒中再灌注治疗的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1004-1011. |
[3] | 张丽苹, 曹黎明, 肖楠, 廖雨琦, 池枫, 余艳妮, 任力杰. 纳米材料在缺血性卒中诊疗中的研究进展及挑战[J]. 中国卒中杂志, 2024, 19(9): 1012-1017. |
[4] | 姜河, 王珵, 陈祥华, 许春香. 五种院前卒中筛查量表对院内急性大血管闭塞性缺血性卒中的预测价值[J]. 中国卒中杂志, 2024, 19(9): 1018-1024. |
[5] | 王晓蕊, 骆嵩, 邹良玉, 屈洪党, 崔雪, 赵玉洁. 嗜酸性粒细胞与单核细胞比值预测急性缺血性卒中患者静脉溶栓预后的价值研究 [J]. 中国卒中杂志, 2024, 19(9): 1025-1033. |
[6] | 王铄, 余苹, 张宁, 王春雪. 2013—2023年缺血性卒中与睡眠相关性研究的文献计量学分析 [J]. 中国卒中杂志, 2024, 19(9): 1040-1047. |
[7] | 周宏宇, 李子孝, 王拥军. 基于影像组学预测大脑年龄与缺血性卒中的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1066-1076. |
[8] | 阿娜古丽·阿不拉尼压孜, 吴晓欣, 李骄星, 李竹浩, 盛文利. 急性缺血性卒中磁敏感血管征影响因素及临床应用的研究进展[J]. 中国卒中杂志, 2024, 19(9): 1077-1085. |
[9] | 杨金波, 张聪. 高分辨率血管壁成像在缺血性卒中患者中的应用进展[J]. 中国卒中杂志, 2024, 19(9): 1086-1093. |
[10] | 吴春艳, 尹雅诗, 王广志, 岳奎涛. 急性缺血性卒中不同时间窗影像学评价及应用进展[J]. 中国卒中杂志, 2024, 19(9): 1094-1101. |
[11] | 王也, 魏宸铭, 李秀丽, 武剑. 多元化教学模式在大学附属教学医院卒中绿色通道培训中的应用[J]. 中国卒中杂志, 2024, 19(9): 1102-1109. |
[12] | 单凯, 赵梦, 王春娟, 李子孝, 王晓岩. 卒中及共患疾病诊疗模式探索与实践 [J]. 中国卒中杂志, 2024, 19(8): 863-865. |
[13] | 梁艳超, 王晓岩, 单凯. 基于DMAIC模型的妊娠合并脑血管病急诊就诊流程优化研究 [J]. 中国卒中杂志, 2024, 19(8): 873-879. |
[14] | 张梦若, 徐守臣, 隋翠翠, 李玉奎, 王雪莉. 下肢康复机器人联合头针治疗对老年缺血性卒中患者步行效率和协调功能影响调查 [J]. 中国卒中杂志, 2024, 19(8): 902-908. |
[15] | 薛明月, 张慧鑫, 苏丹, 李丽霞, 李晶玮, 李虹. 缺血性卒中患者服药依从性影响因素分析 [J]. 中国卒中杂志, 2024, 19(8): 909-914. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||